PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

This is a prospective, randomized, open-label, two-arm phase 2 trial that will evaluate whether the use of Pulsed Low-Dose-Rate radiation technique, as compared to standard radiation, is associated with reduced rates of clinically significant esophagitis during and following chemoradiation.

Trial Details

NCT ID
NCT06906887
Phase
PHASE2
Sponsor
Medical College of Wisconsin
Status
RECRUITING
Cancer Type
Esophageal Cancer
Interventions
  • Induction Chemotherapy (modified FLOT or modified FOLFOX-6)
  • Chemotherapy
  • Conventional Radiation
  • Pulsed Low-Dose-Rate (PLDR) Radiation
  • Surgery
Locations (sample)
  • Milwaukee, Wisconsin, United States|43.0389,-87.90647

Key Eligibility Criteria

  • A potential study subject who meets all of the following inclusion criteria is eligible to participate in the study.
  • Age ≥ 18 years.
  • Stage II-IVb adenocarcinoma of the esophagus (if IVb, oligometastatic only, felt to be eligible for definitive dose CRT treatment by treating physi…
  • Currently receiving or have received induction chemotherapy and planned for definitive dose chemoradiation (+/- esophagectomy).

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Esophageal Cancer Trials on Trialify →